Case Managers Streamline Transfer Process

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 15 No 7
Volume 15
Issue 7

Prescreening patients before transfer from one cancer facility to another gives the receiving hospital an opportunity to prepare needed services for that patient, "thereby maximizing resources and providing quality care more efficiently," Kathy Rogala-Scherer, RN, Department of Case Management, Roswell Park Cancer Institute (RPCI), said at the 31st Annual Congress of the Oncology Nursing Society (abstract 35).

BOSTON—Prescreening patients before transfer from one cancer facility to another gives the receiving hospital an opportunity to prepare needed services for that patient, "thereby maximizing resources and providing quality care more efficiently," Kathy Rogala-Scherer, RN, Department of Case Management, Roswell Park Cancer Institute (RPCI), said at the 31st Annual Congress of the Oncology Nursing Society (abstract 35).

Key information required to streamline the admitting process includes insurance, demographics, history, and special needs status, and pertinent clinical data supporting the cancer diagnosis. Oncology nurse case managers evaluate the information and review it with the accepting oncologist and with the intensivist if a critical care bed is indicated.

"With prescreening, we can better manage the needs of the patients who come to the Institute," Ms. Rogala-Scherer said. "For example, we can adjust if a patient requires a private room because of being MRSA [methicillin-resistant Staphylococcus aureus] positive or if they have physical limitations, such as being morbidly obese and unable to fit into a standard hospital bed." In this initial review of cases in 2005, RPCI accepted 274 transfers; only 10 patients were declined for transfer.

Related Videos
Positive margin rates have not appeared to improve for patients with cancer undergoing surgical care based on several prior studies.
Investigators must continue to explore the space for lisocabtagene maraleucel in mantle cell lymphoma, according to Manali Kamdar, MD.
Those with CML should discuss adverse effects such as nausea or fatigue with their providers to help optimize their quality of life during treatment.
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
Patients with CML can become an active part of their treatment plan by discussing any questions that come to mind with their providers.
A panel of 4 experts on multiple myeloma
Video 1 - 4 KOLs are featured in "Treating Patients Referred to Academic Centers for CAR T"
Video 1 - 4 KOLs are featured in "Identifying Potential Candidates for CAR T-Cell Therapy"
Related Content